2X | Tesamorelin & Ipamorelin | 10/2 mg

10/2 mg lyophilized Tesamorelin & Ipamorelin HA

The potential for research into a peptide blend of Tesamorelin and Ipamorelin is vast and intriguing, given their individual and complementary effects, particularly in terms of growth hormone (GH) regulation and metabolic health. Tesamorelin is a growth hormone-releasing hormone (GHRH) analog known primarily for its efficacy in reducing visceral adipose tissue, while Ipamorelin is a selective growth hormone secretagogue with a strong safety profile.

The combination of these two peptides could offer a synergistic approach to enhancing growth hormone release more effectively and sustainably than either peptide alone. Research into this peptide blend could potentially provide a multifaceted approach to managing conditions associated with GH deficiency, such as sarcopenia (muscle wasting), obesity, and possibly even cognitive health, given GH’s role in brain function.

Please note that all products featured here are intended exclusively for research and development purposes. They are not designed for any form of human consumption. These products have not undergone evaluation by the U.S. Food and Drug Administration.